
Investing for Cures 2025
Landmark’s 14th annual Investing for Cures (IFC 2025) will bring together early, venture, and growth stage companies with HNW Investors, Family Offices and leaders from major pharma, philanthropies and foundations to explore the changing parameters and latest innovative technologies shaping today's advancements and tomorrow's treatments. The two day virtual event will feature presentations from select companies seeking funding and a roster of expert speakers.
A by-invitation event, registration is restricted to Landmark's investor members, Family Office members, and other invited guests. All registrations are subject to review. For more information, please contact admin@landmarkangels.com